Newscenter Media News The ‘reactome’, an AI-powered platform developed by Cambridge and Pfizer, revolutionizes drug design by accurately predicting chemical reactions, streamlining the pharmaceutical development process. Researchers have…
Check Also
Google partners with nuclear startup to power its AI data centers
Search engine giant Google has struck a deal with nuclear Kairos Power to build seven …